Genetically Engineered Microvesicles Carrying Suicide mRNA/Protein Inhibit Schwannoma Tumor Growth
暂无分享,去创建一个
Mehmet Fatih Bolukbasi | Erdogan Pekcan Erkan | X. Breakefield | M. Bolukbasi | Gokhan Baris Ozdener | S. Madlener | G. Brenner | Xandra O Breakefield | Sibylle Madlener | E. Erkan | Thomas Ströbel | O. Saydam | T. Ströbel | Okay Saydam | Arda Mizrak | Gary J Brenner | Arda Mizrak
[1] S. Pomeroy,et al. Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. , 2011, Nature communications.
[2] Laurence Zitvogel,et al. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell derived exosomes , 1998, Nature Medicine.
[3] Jacopo Meldolesi,et al. Shedding microvesicles: artefacts no more. , 2009, Trends in cell biology.
[4] Graça Raposo,et al. The Biogenesis and Functions of Exosomes , 2002, Traffic.
[5] Jian-Bing Fan,et al. miR-1289 and “Zipcode”-like Sequence Enrich mRNAs in Microvesicles , 2012, Molecular therapy. Nucleic acids.
[6] R. Coura,et al. The state of the art of adeno-associated virus-based vectors in gene therapy , 2007, Virology Journal.
[7] A. Régnault,et al. TCR Activation of Human T Cells Induces the Production of Exosomes Bearing the TCR/CD3/ζ Complex1 , 2002, The Journal of Immunology.
[8] Hamid Cheshmi. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers , 2011 .
[9] Z. Hartman,et al. Adenovirus vector induced innate immune responses: impact upon efficacy and toxicity in gene therapy and vaccine applications. , 2008, Virus research.
[10] Parag Aggarwal,et al. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. , 2008, Molecular pharmaceutics.
[11] P. Leroy,et al. In vivo cancer gene therapy by adenovirus-mediated transfer of a bifunctional yeast cytosine deaminase/uracil phosphoribosyltransferase fusion gene. , 2000, Cancer research.
[12] R. Johnstone,et al. Exosomes biological significance: A concise review. , 2006, Blood cells, molecules & diseases.
[13] T. Pisitkun,et al. Urinary exosomes: is there a future? , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[14] X. Breakefield,et al. Brain Tumor Microvesicles: Insights into Intercellular Communication in the Nervous System , 2011, Cellular and Molecular Neurobiology.
[15] M. Kúdelová,et al. Early shutoff of host protein synthesis in cells infected with herpes simplex viruses. , 2001, Acta virologica.
[16] Graça Raposo,et al. Exosomal-like vesicles are present in human blood plasma. , 2005, International immunology.
[17] G. Raposo,et al. Exosomes: a common pathway for a specialized function. , 2006, Journal of biochemistry.
[18] Fátima Sánchez-Cabo,et al. Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells , 2011, Nature communications.
[19] J Ratajczak,et al. Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery , 2006, Leukemia.
[20] E. Meurs,et al. The dsRNA protein kinase PKR: virus and cell control. , 2007, Biochimie.
[21] D. Muruve,et al. Immune responses to adeno-associated virus vectors. , 2005, Current gene therapy.
[22] Rekha C. Patel,et al. PACT, a Stress-modulated Cellular Activator of Interferon-induced Double-stranded RNA-activated Protein Kinase, PKR* , 2000, The Journal of Biological Chemistry.
[23] J. Lötvall,et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.
[24] M. Wood,et al. Biological gene delivery vehicles: beyond viral vectors. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.
[25] F. Bushman,et al. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. , 2008, The Journal of clinical investigation.
[26] R. Blaese,et al. Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor. , 1994, Cancer research.
[27] Gunther Hartmann,et al. SiRNA delivery with exosome nanoparticles , 2011, Nature Biotechnology.
[28] Sascha Keller,et al. Exosomes: from biogenesis and secretion to biological function. , 2006, Immunology letters.
[29] Ming Yi,et al. miRNA-7 attenuation in Schwannoma tumors stimulates growth by upregulating three oncogenic signaling pathways. , 2011, Cancer research.
[30] D. Farber,et al. Transfer of MicroRNAs by Embryonic Stem Cell Microvesicles , 2009, PloS one.
[31] K. Rock,et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization , 2008, Nature Immunology.
[32] A. Stemmer-Rachamimov,et al. A novel imaging-compatible sciatic nerve schwannoma model , 2011, Journal of Neuroscience Methods.
[33] C. Richards,et al. Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[34] M. Hashida,et al. Development of gene drug delivery systems based on pharmacokinetic studies. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[35] Laurence Zitvogel,et al. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming , 2001, Nature Medicine.
[36] Xiankui Li,et al. Establishment and characterization of a schwannoma cell line from a patient with neurofibromatosis 2. , 2002, International journal of oncology.
[37] C. Melief,et al. B lymphocytes secrete antigen-presenting vesicles , 1996, The Journal of experimental medicine.
[38] Shanta M. Messerli,et al. Imaging and therapy of experimental schwannomas using HSV amplicon vector-encoding apoptotic protein under Schwann cell promoter , 2010, Cancer Gene Therapy.
[39] M. McDermott,et al. Meningioma transcript profiles reveal deregulated Notch signaling pathway. , 2005, Cancer research.
[40] Beiyi Shen,et al. Protein Targeting to Exosomes/Microvesicles by Plasma Membrane Anchors* , 2011, The Journal of Biological Chemistry.
[41] H. Chung,et al. Nanomaterials for cancer therapy and imaging , 2011, Molecules and cells.
[42] E. Lechman,et al. Exosomes derived from genetically modified DC expressing FasL are anti-inflammatory and immunosuppressive. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.
[43] X. Breakefield,et al. Microvesicle-associated AAV vector as a novel gene delivery system. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.
[44] R. Stephens,et al. Downregulated MicroRNA-200a in Meningiomas Promotes Tumor Growth by Reducing E-Cadherin and Activating the Wnt/β-Catenin Signaling Pathway , 2009, Molecular and Cellular Biology.
[45] Ralph Weissleder,et al. Glioma therapy and real‐time imaging of neural precursor cell migration and tumor regression , 2005, Annals of neurology.
[46] Feng Liu,et al. Implications of pharmacokinetic behavior of lipoplex for its inflammatory toxicity. , 2005, Advanced drug delivery reviews.
[47] T. D. de Gruijl,et al. Functional delivery of viral miRNAs via exosomes , 2010, Proceedings of the National Academy of Sciences.
[48] M. Wood,et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes , 2011, Nature Biotechnology.
[49] A. Guha,et al. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells , 2008, Nature Cell Biology.